These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1542100)
1. Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity. Glennon RA; Raghupathi R; Bartyzel P; Teitler M; Leonhardt S J Med Chem; 1992 Feb; 35(4):734-40. PubMed ID: 1542100 [TBL] [Abstract][Full Text] [Related]
2. Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding. Herndon JL; Ismaiel A; Ingher SP; Teitler M; Glennon RA J Med Chem; 1992 Dec; 35(26):4903-10. PubMed ID: 1479590 [TBL] [Abstract][Full Text] [Related]
3. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand. Titeler M; Lyon RA; Davis KH; Glennon RA Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239 [TBL] [Abstract][Full Text] [Related]
4. N-methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Glennon RA; Titeler M; Seggel MR; Lyon RA J Med Chem; 1987 May; 30(5):930-2. PubMed ID: 3572981 [TBL] [Abstract][Full Text] [Related]
5. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Hoyer D; Pazos A; Probst A; Palacios JM Brain Res; 1986 Jun; 376(1):97-107. PubMed ID: 2941113 [TBL] [Abstract][Full Text] [Related]
6. 5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues. Glennon RA; McKenney JD; Lyon RA; Titeler M J Med Chem; 1986 Feb; 29(2):194-9. PubMed ID: 3950904 [TBL] [Abstract][Full Text] [Related]
7. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353 [TBL] [Abstract][Full Text] [Related]
8. Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist. Ismaiel AM; De Los Angeles J; Teitler M; Ingher S; Glennon RA J Med Chem; 1993 Aug; 36(17):2519-25. PubMed ID: 8355253 [TBL] [Abstract][Full Text] [Related]
9. Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites. Canton H; Verrièle L; Colpaert FC Eur J Pharmacol; 1990 Nov; 191(1):93-6. PubMed ID: 1982659 [TBL] [Abstract][Full Text] [Related]
10. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding. Pranzatelli MR; Murthy JN; Pluchino RS J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361 [TBL] [Abstract][Full Text] [Related]
11. Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors. Choudhary MS; Craigo S; Roth BL Mol Pharmacol; 1992 Oct; 42(4):627-33. PubMed ID: 1435740 [TBL] [Abstract][Full Text] [Related]
12. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist. Pranzatelli MR Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895 [TBL] [Abstract][Full Text] [Related]
13. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain. Pranzatelli MR; Gregory CM Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108 [TBL] [Abstract][Full Text] [Related]
14. A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors. Choudhary MS; Craigo S; Roth BL Mol Pharmacol; 1993 May; 43(5):755-61. PubMed ID: 8388989 [TBL] [Abstract][Full Text] [Related]
15. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons. Sheldon PW; Aghajanian GK Synapse; 1991 Nov; 9(3):208-18. PubMed ID: 1776132 [TBL] [Abstract][Full Text] [Related]
16. Binding sites for 5-hydroxytryptamine-2 receptor agonists are predominantly located in striosomes in the human basal ganglia. Waeber C; Palacios JM Brain Res Mol Brain Res; 1994 Jul; 24(1-4):199-209. PubMed ID: 7968358 [TBL] [Abstract][Full Text] [Related]
17. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors. Lyon RA; Davis KH; Titeler M Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649 [TBL] [Abstract][Full Text] [Related]
18. 1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists. Dowd CS; Herrick-Davis K; Egan C; DuPre A; Smith C; Teitler M; Glennon RA J Med Chem; 2000 Aug; 43(16):3074-84. PubMed ID: 10956215 [TBL] [Abstract][Full Text] [Related]
19. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor. Branchek T; Adham N; Macchi M; Kao HT; Hartig PR Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697 [TBL] [Abstract][Full Text] [Related]
20. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines. Nelson DL; Lucaites VL; Audia JE; Nissen JS; Wainscott DB J Pharmacol Exp Ther; 1993 Jun; 265(3):1272-9. PubMed ID: 8510008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]